These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1618895)

  • 1. Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells.
    Huland E; Huland H
    J Cancer Res Clin Oncol; 1992; 118(6):463-7. PubMed ID: 1618895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma.
    Huland E; Huland H
    Cancer Res; 1989 Oct; 49(19):5469-74. PubMed ID: 2788500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of local, continuous and cyclic, high-dose bladder perfusion with recombinant and natural interleukin-2 in advanced cancer of the urinary bladder.
    Schwaibold H; Huland E; Heinzer H; Schwuléra U; Huland H
    J Cancer Res Clin Oncol; 1995; 121(4):239-46. PubMed ID: 7751323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development.
    Persson CG; Erjefält JS
    Trends Pharmacol Sci; 1997 Apr; 18(4):117-23. PubMed ID: 9149540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration.
    Sosman JA; Bartemes K; Offord KP; Kita H; Fisher SG; Kefer C; Ellis TA; Fisher RI; Higgins TJ; Gleich GJ
    Clin Cancer Res; 1995 Aug; 1(8):805-12. PubMed ID: 9816049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease.
    Erjefält JS; Greiff L; Andersson M; Adelroth E; Jeffery PK; Persson CG
    Thorax; 2001 May; 56(5):341-4. PubMed ID: 11312400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H; Loegering DA; Kita H; Kephart GM; Gleich GJ
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
    Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
    Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells.
    Silberstein DS; Schoof DD; Rodrick ML; Tai PC; Spry CJ; David JR; Eberlein TJ
    J Immunol; 1989 Mar; 142(6):2162-7. PubMed ID: 2784151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil, eosinophilia, and eosinophilic disorders.
    Tavassoli M
    Crit Rev Clin Lab Sci; 1981; 16(1):35-83. PubMed ID: 7035066
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.
    Foong A; Scholes JV; Gleich GJ; Kephart GM; Holt PR
    Hepatology; 1991 Jun; 13(6):1090-4. PubMed ID: 2050327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma.
    Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB
    Clin Exp Allergy; 1992 Feb; 22(2):265-73. PubMed ID: 1373987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypereosinophilic syndrome human eosinophil degranulation induced by soluble and particulate stimuli.
    Henderson WR; Harley JB; Fauci AS; Chi EY
    Br J Haematol; 1988 May; 69(1):13-21. PubMed ID: 3132964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic eosinophilic pneumonia and idiopathic bronchiolitis obliterans organizing pneumonia: comparison of eosinophil number and degranulation by immunofluorescence staining for eosinophil-derived major basic protein.
    Olopade CO; Crotty TB; Douglas WW; Colby TV; Sur S
    Mayo Clin Proc; 1995 Feb; 70(2):137-42. PubMed ID: 7531262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of interleukin-2 in human peripheral blood eosinophils.
    Levi-Schaffer F; Barkans J; Newman TM; Ying S; Wakelin M; Hohenstein R; Barak V; Lacy P; Kay AB; Moqbel R
    Immunology; 1996 Jan; 87(1):155-61. PubMed ID: 8666429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer.
    van Haelst Pisani C; Kovach JS; Kita H; Leiferman KM; Gleich GJ; Silver JE; Dennin R; Abrams JS
    Blood; 1991 Sep; 78(6):1538-44. PubMed ID: 1884020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy.
    Mueller S; Aigner T; Neureiter D; Stolte M
    J Clin Pathol; 2006 Nov; 59(11):1175-80. PubMed ID: 16556666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil activation and function in health and disease.
    Abu-Ghazaleh RI; Kita H; Gleich GJ
    Immunol Ser; 1992; 57():137-67. PubMed ID: 1504137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial edema and eosinophilia. Evidence for eosinophil degranulation.
    Songsiridej V; Peters MS; Dor PJ; Ackerman SJ; Gleich GJ; Busse WW
    Ann Intern Med; 1985 Oct; 103(4):503-6. PubMed ID: 3898950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.